Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Medicina
versión On-line ISSN 1561-302X
Resumen
BUCHACA FAXAS, Emilio F. et al. Hepatic steatosis in type 2 diabetes patients and its relationship with glycemic control. Rev cubana med [online]. 2019, vol.58, n.3 Epub 24-Jun-2020. ISSN 1561-302X.
Introduction:
Non-alcoholic liver steatosis is the most frequent disease in the world. It is associated with type 2 diabetes mellitus, representing great economic-social impact.
Objective:
To describe the behavior of hepatic steatosis in a population of patients diagnosed with type 2 diabetes mellitus.
Methods:
An observational, descriptive, cross-sectional study was conducted in 94 diabetic patients treated at Hermanos Ameijeiras Clinical Surgical Hospital, from February 2016 to February 2018.
Results:
Steatosis was mild in 42.6%, moderate (44.7%) and severe in 12.8%, with a mainly indeterminate NAFLD score (72.3%). F0-1 fibrosis was detected in 58.5% of the patients, F2 (29.8%) and significant (F3 and F4) in 11.7%). Association between increased liver echogenicity, diffuse liver pattern and severe degree of steatosis were ostensible by ultrasound with higher degree of fibrosis according to elastography. Significant relationship of elevated levels of HBA1C with significant fibrosis was detected, measured both by NAFLD score and by elastography.
Conclusions:
Hepatic steatosis present in patients with diabetes mellitus was mainly mild to moderate with prevalence of mild fibrosis, the degree of significant fibrosis was associated with increased liver echogenicity, diffuse liver pattern, severe degree of steatosis by ultrasound and high levels of hemoglobin. glycosylated.
Palabras clave : diabetes mellitus; non-alcoholic liver steatosis; nonalcoholic fatty liver disease.